PangCe Medical Completes Tens of Millions of RMB Pre-B Financing and Unveils Multiple New Products at the 8th Asian Hair Transplantation Summit

VCBeat has learned at the earliest opportunity that,Puncture Robotic (Shanghai) Intelligent Medical Technology Co., Ltd. (hereinafter referred to as “Puncture Robotic”)Announced the completion of a pre-B financing round worth tens of millions of yuan. This round of financing was led byHefei Innovation InvestmentLead investor,Yongjie FundandYuefu FundCo-investment; the funds will be primarily used for market promotion and product R&D to accelerate the intelligent development of the hair care industry.

Meanwhile, at the recently held 8th Asian Hair Transplant Conference and the 7th Chinese Hair Transplant Conference, Puncture Robotic made a stunning debut at Booth [Special 5], showcasing its first-, second-, and third-generation hair transplant robots alongside the newly launched HairTracker 3S Intelligent Hair Grading and Identification System. The company presented a more scientific, effective, and intelligent one-stop smart hair management solution for the 250 million patients suffering from hair loss.

Photos of Puncture Robotic’s 3rd-Generation Hair Transplant Robot at the Asian Hair Transplantation Conference

As the first intelligent medical enterprise in China to engage in the research and development of hair transplant robots, Puncture Robotic was initially incubated and supported by Academician Sun Lining and the Harbin Institute of Technology’s robotics system. After years of dedicated development, the company has established the most comprehensive domestic product pipeline currently under development for third-generation hair transplant robots, along with a product layout covering the entire preoperative, intraoperative, and postoperative processes. It has accumulated nearly 200 patents and intellectual property rights. During the research and development of hair transplant robots, Puncture Robotic received strong support from the team led by Professor Wu Wenyu, Director of the Department of Dermatology at Huashan Hospital Affiliated to Fudan University. This close collaboration among industry, academia, research, and clinical practice has laid a solid foundation for the company’s development.

HAIRO^®Group Photo of Experts at the Clinical Summary Meeting for Hair Transplant Robots

Its self-developed first-generation hair transplant robot, HAIRO^®, specifically designed for the hair characteristics of Asians, it accurately identifies hair follicles using 3D vision positioning technology and employs algorithms to plan and control a robotic arm for follicular unit extraction. Integrated with robotic force protection and patient motion tracking features, it ensures high efficiency, precision, and safety during the procedure. Compared to manual extraction, it offers significant advantages in terms of wound trauma, integrity of follicular puncture, multi-hair follicle extraction rate, treatment efficiency, and patient experience. Furthermore, the hair transplant robot provides precise controllability and high treatment consistency, alleviating physicians’ workload and serving as an valuable assistant to hair transplant surgeons, thereby delivering intelligent, standardized, and safe hair restoration services to patients.

November 2023, HAIRO^®️The hair transplant robot has successfully completed enrollment for all clinical trials, becoming the first hair transplant robot in China to achieve full clinical trial enrollment.

HAIRO^®️Hair Transplant Robot

Puncture Robotic’s second-generation hair transplantation robot, Normanrobo™, integrates both extraction and implantation functions. The company has reached preliminary agreements with several renowned hospitals, including Huashan Hospital Affiliated to Fudan University, Shanghai Ninth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Plastic Surgery Hospital of the Chinese Academy of Medical Sciences, and Nanfang Hospital of Southern Medical University, to jointly conduct registration clinical trials for China’s first all-in-one hair transplantation robot capable of both harvesting and implantation.

Normanrobo™ Second-Generation Hair Transplant Robot

The third-generation hair transplant robot, HAIRO L™, features comprehensive upgrades in device size, flexibility, and long-hair extraction technology. As the world’s first device to support long-hair extraction, it offers patients a new option for non-shaven hair transplantation, thereby avoiding the awkward phase associated with shaving required by conventional procedures.

HAIRO L™ Third-Generation Hair Transplant Robot

Another highlight of the exhibition was the HairTracker 3S Intelligent Hair Grading and Assessment Device, which integrates the internationally recognized BASP and Norwood-Hamilton hair loss classification standards. Leveraging advanced artificial intelligence algorithms, it provides intelligent, precise, and rapid hair grading and assessment services for clinicians. This enables doctors to quickly establish patient profiles, record real-time hair status, and facilitate efficient retrieval and follow-up of treatment progress, thereby reducing reliance on subjective experience and enhancing diagnostic and therapeutic efficiency.

HairTracker 3S Intelligent Hair Grading and Identification Device

Puncture Robotic is not only dedicated to the continuous innovation of hair transplantation technologies but also actively invests in the research and development of advanced products for hair diagnosis, surgical procedures, and hair maintenance and stabilization. In addition to the HairTracker 3S Intelligent Hair Grading and Identification System, it offers equipment such as scalp anti-aging treatment devices. By providing hospitals and institutions with comprehensive solutions centered on hair transplantation robots—integrating hair care, transplantation, protection, and stabilization—Puncture Robotic is creating a new generation of hair disorder diagnosis and treatment solutions.

The team at Hefei Innovation Sci-tec Venture Capital stated that China’s hair transplant medical services market is in a phase of rapid development. With growing public awareness of personal appearance and increasing acceptance of hair transplant procedures, the introduction of hair transplant robots can effectively alleviate the current pressure on medical staff in the industry. Through its Chan Tou Zhu Chao fund, Hefei Innovation Sci-tec Venture Capital has provided support to Puncture Robotic, aiming to foster the development of the domestically produced surgical robot sector.

The investment team of Yuefu Fund stated: The medical device industry, and specifically the surgical robotics segment in which Puncture Robotic operates, is an emerging sector in China with broad development prospects, making it a key area of focus for our team. The hair transplantation and prostate biopsy markets, where Puncture Robotic currently concentrates its efforts, offer substantial market potential. Leveraging the industrial technology ecosystem of the HIT Robot Group, Puncture Robotic is a technology-driven enterprise that integrates healthcare, robotics, and artificial intelligence. Its core team members have deep expertise in the robotics and medical fields, backed by extensive resources and practical implementation experience. The company’s hair transplantation robot is poised to become the first such product successfully launched in the domestic market. We are highly optimistic about Puncture Robotic’s growth in the fields of hair transplantation and percutaneous puncture procedures.

Hefei Innovation Sci-tec Venture Capital Co., Ltd. (Hefei Innovation VC), established in August 2000, is one of the earliest venture capital institutions founded in Anhui Province and a highly specialized and market-oriented venture capital firm within the Hefei State-owned Assets Supervision and Administration Commission system. The company primarily engages in venture capital investment, entrusted fund management, and fund initiation, focusing on technology-driven enterprises, particularly those in the start-up and early-to-mid growth stages. Its assets under management have exceeded RMB 10 billion, and it has supported over 600 companies to date. The company has been consecutively recognized as one of China’s Top 50 Influential VC Institutions, Top 50 State-owned Investment Institutions, Top 50 Influential State-owned Investment Institutions, and Top 50 Nationally Registered Venture Capital Institutions.

Guangzhou Yuefu Fund Management Co., Ltd. (hereinafter referred to as “Yuefu Fund”) is a Yuexiu District industrial investment fund jointly established by Guangzhou Yuexiu State-owned Assets Investment and Operation Company (the capital contribution channel of the Yuexiu District People’s Government of Guangzhou) and Guangzhou Financial Holdings Fund Management Co., Ltd. (the capital contribution channel of the Guangzhou Municipal People’s Government). It serves as a district-level fund-based investment and financing platform established by Yuexiu District, Guangzhou, to amplify the guiding effect of government investment funds, attract the agglomeration of financial institutions, promote the construction of a financial innovation service zone, and build a financial holding platform.